Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Mannequin-Based Simulation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Mannequin-Based Simulation Market to Reach $5 Billion by 2027
Amid the COVID-19 crisis, the global market for Mannequin-Based Simulation estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$5 Billion by 2027, growing at a CAGR of 22% over the period 2020-2027.
Patient Simulators, one of the segments analyzed in the report, is projected to record 18.5% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Segments segment is readjusted to a revised 27.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $367.5 Million, While China is Forecast to Grow at 21.7% CAGR
The Mannequin-Based Simulation market in the U.S. is estimated at US$367.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$876.2 Million by the year 2027 trailing a CAGR of 21.7% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.2% and 19% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.
Select Competitors (Total 52 Featured):
- 3D Systems, Inc.
- CAE Healthcare
- Gaumard Scientific Company Inc.
- Laerdal Medical A/S
- Limbs & Things Ltd.
- Mentice AB
- Simulab Corporation
- Simulaids Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Mannequin - A Prelude
- Recent Market Activity
- Simulation Training
- Mannequin-based Simulation: Increasingly Vital in Physician Training
- Growth Drivers
- Increasing Focus on Patient Safety
- Limited Access to Live Patients Drives Market for Simulation
- Simulation in Healthcare Enables Cost Reduction
- Technology Revolution Drives Demand for Simulation
- Market Challenges
- High Entry-Price Points Restrict Market
- Developed Regions: Primary Revenue Contributors
- Developing Regions Offer High Growth Potential for Mannequin-based Simulation
- Competition
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 52 Featured)
- 3D Systems (USA)
- CAE Healthcare (Canada)
- Gaumard Scientific Company, Inc. (USA)
- Kyoto Kagaku Co., Ltd. (Japan)
- Laerdal Medical A/S (Norway)
- Limbs & Things Ltd. (UK)
- Mentice AB (Sweden)
- Shanghai Honglian Medical Tech Group (China)
- Simulab Corporation (USA)
- Simulaids, Inc. (USA)
3. MARKET TRENDS & DRIVERS
- Advanced Mannequins Imitate Human Reactions
- Increasing Healthcare Expenditure to Foster Growth
- Mannequin-based Simulation for Nursing Schools
- Mannequins Gain Traction in Military Medical Training
- Minimally-invasive Procedures Necessitate Simulation-based Training
- Robot-assisted Surgical Simulation Training Gaining Significance
- Simulation Training Preferred for Cataract Surgery
- Simulation Benefits Interventional Cardiology
- Innovations in Patient Simulators
- Virtual Medical Training - Potential to Replace Mannequin-based Simulation
4. GLOBAL MARKET PERSPECTIVE
- World 15-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
- World 15-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 52
For more information about this report visit https://www.researchandmarkets.com/r/440u1b
